These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1219688)

  • 21. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the fenfluramine derivative 'S992' on body-weight and blood lipids in man.
    Pawan GL; Payne PM; Sheldrick EC
    Proc Nutr Soc; 1971 May; 30(1):8A-9A. PubMed ID: 5090498
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparisons between the behavioural and anorexic effects of 780SE and other phenylethylamines in the rat.
    Taylor M; Goudie AJ
    Postgrad Med J; 1975; 51 Suppl 1():56-65. PubMed ID: 1219680
    [No Abstract]   [Full Text] [Related]  

  • 24. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
    Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
    Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine.
    Otim MA
    East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093
    [No Abstract]   [Full Text] [Related]  

  • 27. [Behavior of blood copper in diabetes and its possible relations to nonesterified fatty acids].
    Faelli U; Giordani G
    Minerva Med; 1971 Sep; 62(68):3186-90. PubMed ID: 5163600
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
    Malmlöf K; Golozoubova V; Peschke B; Wulff BS; Refsgaard HH; Johansen PB; Cremers T; Rimvall K
    Obesity (Silver Spring); 2006 Dec; 14(12):2154-62. PubMed ID: 17189541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihyperglycaemic and antihyperlipidaemic effects of Nymphaea stellata in alloxan-induced diabetic rats.
    Rajagopal K; Sasikala K
    Singapore Med J; 2008 Feb; 49(2):137-41. PubMed ID: 18301841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of mediator of glucose metabolism: pharmacological and clinical synthesis].
    Giraudet-Wentz MC
    Journ Annu Diabetol Hotel Dieu; 1979; ():325-32. PubMed ID: 502138
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial of fenfluramine in the treatment of obesity in Thai people.
    Chandraprasert S; Israsena T
    Mod Med Asia; 1977 Dec; 13(12):10-2. PubMed ID: 604778
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical studies on the effect of S-1,3-butanediol of diabetes induced rats.
    Meenakshi C; Kumari KL; Devi CS
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):145-8. PubMed ID: 7649603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
    Wilton D
    Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihyperlipidaemic effect of Gymnema montanum: a study on lipid profile and fatty acid composition in experimental diabetes.
    Ramkumar KM; Vijayakumar RS; Ponmanickam P; Velayuthaprabhu S; Archunan G; Rajaguru P
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):538-45. PubMed ID: 19067681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood lipid balance in simple diabetes mellitus or diabetes with excess weight, in relation to age and sex (epidemiological study)].
    Mincu I; Câmpeanu S; Dumitrescu C; Mihalache N; Ionescu D
    Med Interna (Bucur); 1971 Dec; 23(12):1455-70. PubMed ID: 5159282
    [No Abstract]   [Full Text] [Related]  

  • 38. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
    Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
    Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+)-Z-Bisdehydrodoisynolic acid ameliorates obesity and the metabolic syndrome in female ZDF rats.
    Banz WJ; Davis J; Steinle JJ; Adler S; Oitker J; Winters TA; Higginbotham DA; Hou Y; Henry N; Peterson R; Meyers CY
    Obes Res; 2005 Nov; 13(11):1915-24. PubMed ID: 16339123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts.
    Tomlinson SA; Lines JG; Greenfield MA
    Postgrad Med J; 1975; 51 Suppl 1(593):166-70. PubMed ID: 768962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.